GB0524375D0 - Novel liquid composition in vitro biologically active to viral infections - Google Patents

Novel liquid composition in vitro biologically active to viral infections

Info

Publication number
GB0524375D0
GB0524375D0 GBGB0524375.3A GB0524375A GB0524375D0 GB 0524375 D0 GB0524375 D0 GB 0524375D0 GB 0524375 A GB0524375 A GB 0524375A GB 0524375 D0 GB0524375 D0 GB 0524375D0
Authority
GB
United Kingdom
Prior art keywords
biologically active
liquid composition
viral infections
novel liquid
vitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0524375.3A
Other versions
GB2432528B (en
GB2432528A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0524375A priority Critical patent/GB2432528B/en
Publication of GB0524375D0 publication Critical patent/GB0524375D0/en
Publication of GB2432528A publication Critical patent/GB2432528A/en
Application granted granted Critical
Publication of GB2432528B publication Critical patent/GB2432528B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0524375A 2005-11-29 2005-11-29 Anti-viral compositions comprising flavanone glycosides and fruit acids Expired - Fee Related GB2432528B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0524375A GB2432528B (en) 2005-11-29 2005-11-29 Anti-viral compositions comprising flavanone glycosides and fruit acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0524375A GB2432528B (en) 2005-11-29 2005-11-29 Anti-viral compositions comprising flavanone glycosides and fruit acids

Publications (3)

Publication Number Publication Date
GB0524375D0 true GB0524375D0 (en) 2006-01-04
GB2432528A GB2432528A (en) 2007-05-30
GB2432528B GB2432528B (en) 2011-04-06

Family

ID=35601498

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0524375A Expired - Fee Related GB2432528B (en) 2005-11-29 2005-11-29 Anti-viral compositions comprising flavanone glycosides and fruit acids

Country Status (1)

Country Link
GB (1) GB2432528B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2687172C (en) * 2007-06-12 2013-09-03 Hiroshima University Anti-norovirus agent and composition containing the same
JP5421901B2 (en) 2008-03-31 2014-02-19 国立大学法人広島大学 Antiviral agent and antiviral composition against non-enveloped viruses of the genus Enterovirus
ES2729777T3 (en) * 2012-08-24 2019-11-06 Citrox Biosciences Ltd Bioflavonoid Coated Materials

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9502244D0 (en) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
DE19809304A1 (en) * 1998-03-05 1999-09-09 Merck Patent Gmbh Formulations with an antiviral effect
US6261589B1 (en) * 1999-03-02 2001-07-17 Durk Pearson Dietary supplement nutrient soft drink composition with psychoactive effect
DE10244397A1 (en) * 2002-09-24 2004-04-01 Basf Ag Choline formulations

Also Published As

Publication number Publication date
GB2432528B (en) 2011-04-06
GB2432528A (en) 2007-05-30

Similar Documents

Publication Publication Date Title
HRP20130720T1 (en) Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
EP1885173A4 (en) Chloroplasts engineered to express pharmaceutical proteins
SG10201501376XA (en) Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
GB0519717D0 (en) Improvements in or relating to devices
GB0411205D0 (en) Improvements in or relating to compositions
GB0520931D0 (en) Improvements in or relating to compositions
ZA200802220B (en) Improvements in or relating to compositions
GB0524375D0 (en) Novel liquid composition in vitro biologically active to viral infections
MA28846B1 (en) BIOLOGICALLY ACTIVE COMPOSITION
GB2417472B (en) Improvements in or relating to airships
EP1909815A4 (en) Novel biologically active peptides and their new uses
GB2426239B (en) Improvements in or relating to stairlifts
GB0515892D0 (en) Improvements in or relating to the manufacture of composites
GB0524835D0 (en) Improvements in and relating to image articles
GB0424012D0 (en) Improvements in or relating to compositions
GB0424013D0 (en) Improvements in or relating to compositions
GB2428664B (en) Improvements in or relating to stairlifts
GB0523384D0 (en) Improvements in or relating to articles of tableware
GB2430692B (en) Improvements in or relating to frames
ZA200707546B (en) Improvements in or relating to compositions
GB0518939D0 (en) Improvements in or relating to compositions
GB0522556D0 (en) Improvements in or relating to compositions
TH87393B (en) sanitary ware
GB2429448B (en) Improvements in or relating to stairlifts
GB0520774D0 (en) Improvements in & relating to bins

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20121129